PRJNA862909
RNA-seq of livers treated with corilagin
Nonalcoholic fatty liver disease (NAFLD) has been considered to be most commonchronic liver diseases. However, no validated pharmacological therapies have been officially proved in clinic due to its complex pathogenesis. The purpose of this study was to examine the protective effects of Corilagin (referred to Cori) against NAFLD in mice under a high fat Corilagin prevents NAFLD development.on diet (HFD) condition.